MUC1 Mouse Monoclonal Antibody [PSH0-48]
Catalog# HA601141
MUC1 Mouse Monoclonal Antibody [PSH0-48]
-
IHC-P
-
FC
-
IF-Cell
-
mIHC
-
Human
-
unconjugated
Overview
Product Name
MUC1 Mouse Monoclonal Antibody [PSH0-48]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Synthetic peptide of core peptide domain of human MUC1.
Species Reactivity
Human
Validated Applications
IHC-P, FC, IF-Cell, mIHC
Molecular Weight
Predicted band size: 122 kDa
Positive Control
Human breast carcinoma tissue, human kidney tissue, human lung tissue, human tonsil tissue, HeLa, SK-Br-3.
Conjugation
unconjugated
Clone Number
PSH0-48
RRID
Reactivity Data
| IHC-P | FC | IF-Cell | mIHC | |
|---|---|---|---|---|
| Human |
|
|
|
|
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG2a
Purification Method
Protein A affinity purified.
Application Dilution
-
IHC-P
-
1:5,000-1:10,000
-
FC
-
1:500-1:1,000
-
IF-Cell
-
1:500
-
mIHC
-
1:8,000
Target
Function
This gene encodes a membrane-bound protein that is a member of the mucin family. Mucins are O-glycosylated proteins that play an essential role in forming protective mucous barriers on epithelial surfaces. These proteins also play a role in intracellular signaling. This protein is expressed on the apical surface of epithelial cells that line the mucosal surfaces of many different tissues including lung, breast stomach and pancreas. This protein is proteolytically cleaved into alpha and beta subunits that form a heterodimeric complex. The N-terminal alpha subunit functions in cell-adhesion and the C-terminal beta subunit is involved in cell signaling. Overexpression, aberrant intracellular localization, and changes in glycosylation of this protein have been associated with carcinomas. This gene is known to contain a highly polymorphic variable number tandem repeats (VNTR) domain. Alternate splicing results in multiple transcript variants.
Background References
1. Taylor-Papadimitriou J. et. al. Latest developments in MUC1 immunotherapy. Biochem Soc Trans. 2018 Jun
2. Kato K. et. al. MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function. J Clin Med. 2017 Nov
Tissue Specificity
Expressed on the apical surface of epithelial cells, especially of airway passages, breast and uterus. Also expressed in activated and unactivated T-cells. Overexpressed in epithelial tumors, such as breast or ovarian cancer and also in non-epithelial tumor cells. Isoform Y is expressed in tumor cells only.
Post-translational Modification
Highly glycosylated (N- and O-linked carbohydrates and sialic acid). O-glycosylated to a varying degree on serine and threonine residues within each tandem repeat, ranging from mono- to penta-glycosylation. The average density ranges from about 50% in human milk to over 90% in T47D breast cancer cells. Further sialylation occurs during recycling. Membrane-shed glycoproteins from kidney and breast cancer cells have preferentially sialyated core 1 structures, while secreted forms from the same tissues display mainly core 2 structures. The O-glycosylated content is overlapping in both these tissues with terminal fucose and galactose, 2- and 3-linked galactose, 3- and 3,6-linked GalNAc-ol and 4-linked GlcNAc predominating. Differentially O-glycosylated in breast carcinomas with 3,4-linked GlcNAc. N-glycosylation consists of high-mannose, acidic complex-type and hybrid glycans in the secreted form MUC1/SEC, and neutral complex-type in the transmembrane form, MUC1/TM.; Proteolytic cleavage in the SEA domain occurs in the endoplasmic reticulum by an autoproteolytic mechanism and requires the full-length SEA domain as well as requiring a Ser, Thr or Cys residue at the P + 1 site. Cleavage at this site also occurs on isoform MUC1/X but not on isoform MUC1/Y. Ectodomain shedding is mediated by ADAM17.; Dual palmitoylation on cysteine residues in the CQC motif is required for recycling from endosomes back to the plasma membrane.; Phosphorylated on tyrosines and serine residues in the C-terminal. Phosphorylation on tyrosines in the C-terminal increases the nuclear location of MUC1 and beta-catenin. Phosphorylation by PKC delta induces binding of MUC1 to beta-catenin/CTNNB1 and thus decreases the formation of the beta-catenin/E-cadherin complex. Src-mediated phosphorylation inhibits interaction with GSK3B. Src- and EGFR-mediated phosphorylation on Tyr-1229 increases binding to beta-catenin/CTNNB1. GSK3B-mediated phosphorylation on Ser-1227 decreases this interaction but restores the formation of the beta-cadherin/E-cadherin complex. On T-cell receptor activation, phosphorylated by LCK. PDGFR-mediated phosphorylation increases nuclear colocalization of MUC1CT and CTNNB1.; The N-terminal sequence has been shown to begin at position 24 or 28.
Subcellular Location
Apical cell membrane. Secreted. Nucleus, Cell membrane, Cytoplasm.
UNIPROT
Synonyms
ADMCKD antibody
ADMCKD1 antibody
Breast carcinoma associated antigen DF3 antibody
Breast carcinoma-associated antigen DF3 antibody
CA 15-3 antibody
CA15 3 antibody
CA15 3 antigen antibody
CA15-3 antibody
CA15.3 antibody
Cancer antigen 15-3 antibody
ExpandImages
-
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with Mouse anti-MUC1 antibody (HA601141) at 1/10,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601141) at 1/10,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Mouse anti-MUC1 antibody (HA601141) at 1/10,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601141) at 1/10,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human lung tissue with Mouse anti-MUC1 antibody (HA601141) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601141) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human tonsil tissue with Mouse anti-MUC1 antibody (HA601141) at 1/10,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA601141) at 1/10,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
☑ Relative expression (RE)
Immunocytochemistry analysis of HeLa (positive) and HCT 116 (negative) labeling MUC1 with Mouse anti-MUC1 antibody (HA601141) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-MUC1 antibody (HA601141) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) were used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of SK-Br-3 cells labeling MUC1.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA601141, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for 30 minutes, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Flow cytometric analysis of HeLa cells labeling MUC1.
Cells were washed twice with cold PBS and resuspend. Then stained with the primary antibody (HA601141, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for 30 minutes, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Lung adenocarcinoma
Sample: Paraffin-embedded section
Primary antibody dilution: 1/10,000
Antigen retrieval: Heat-mediated, Tris-EDTA buffer (pH 9.0), 20 minutes
Platform: Leica Biosystems BOND® RX
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Products with the same target and pathway
Muc1 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P
Reactivity: Human
Conjugate: unconjugated
MUC1 Mouse Monoclonal Antibody [PSH0-47]
Application: IHC-P,WB
Reactivity: Human
Conjugate: unconjugated
MUC1 Mouse Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
MUC1 Mouse Monoclonal Antibody [A9G4]
Application: IHC-P,IF-Cell
Reactivity: Human
Conjugate: unconjugated
MUC1 Recombinant Rabbit Monoclonal Antibody [SN06-80] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
MUC1 Mouse Monoclonal Antibody [A4D9]
Application: IHC-P,FC,IF-Cell
Reactivity: Human
Conjugate: unconjugated
iFluor™ 647 Conjugated MUC1 Mouse Monoclonal Antibody [PSH0-48]
Application: FC
Reactivity: Human
Conjugate: iFluor™ 647
MUC1 Mouse Monoclonal Antibody [PSH0-49]
Application: IHC-P,FC,IF-Cell
Reactivity: Human
Conjugate: unconjugated
iFluor™ 647 Conjugated MUC1 Mouse Monoclonal Antibody [PSH0-49]
Application: FC
Reactivity: Human
Conjugate: iFluor™ 647
